Article
Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5
medRxiv · 2022 · Tamura, T.; Yamasoba, D.; Oda, Y.; Ito, J.; Kamasaki, T.; Nao, N.; Hashimoto, R.; Fujioka, Y.; Suzuki, R.; Wang, L.; Ito, H.; Kimura, I.; Yokota, I.; Kishimoto, M.; Tsuda, M.; Sawa, H.; Yoshimatsu, K.; Ohba, Y.; Yamamoto, Y.; Nagamoto, T.; Kanamune, J.; The Genotype to Phenotype Japan (G2P-Japan) Consortium,; Matsuno, K.; Takayama, K.; Tanaka, S.; Sato, K.; Fukuhara, T.
Key facts
| Title | Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5 |
|---|---|
| First author | Tamura, T.; Yamasoba, D.; Oda, Y.; Ito, J.; Kamasaki, T.; Nao, N.; Hashimoto, R.; Fujioka, Y.; Suzuki, R.; Wang, L.; Ito, H.; Kimura, I.; Yokota, I.; Kishimoto, M.; Tsuda, M.; Sawa, H.; Yoshimatsu, K.; Ohba, Y.; Yamamoto, Y.; Nagamoto, T.; Kanamune, J.; The Genotype to Phenotype Japan (G2P-Japan) Consortium, ; Matsuno, K.; Takayama, K.; Tanaka, S.; Sato, K.; Fukuhara, T. |
| Journal | medRxiv |
| Published | Aug 5, 2022 |
| DOI | 10.1101/2022.08.05.502758 |
| Devices mentioned | K800781 |
| Product codes mentioned | GIA, JJH, JRR, PFF, PFT, KIS |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1